Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.
about
Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypesIdentification of drug resistant mutations in HIV-1 CRF07_BC variants selected by nevirapine in vitroGenetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International SitesHIV-1 Variants and Drug Resistance in Pregnant Women from Bata (Equatorial Guinea): 2012-2013HIV-1 Genetic Variability and Clinical ImplicationsComparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C.Diversity of HIV-1 subtype B: implications to the origin of BF recombinantsThe K65R mutation in HIV-1 reverse transcriptase: genetic barriers, resistance profile and clinical implications.Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirine.Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates.A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1Subtype-associated differences in HIV-1 reverse transcription affect the viral replication.Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs.Clinical management of HIV drug resistance.Subtype-specific analysis of the K65R substitution in HIV-1 that confers hypersusceptibility to a novel nucleotide-competing reverse transcriptase inhibitor.Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs.In Silico and In Vitro Comparison of HIV-1 Subtypes B and CRF02_AG Integrases Susceptibility to Integrase Strand Transfer Inhibitors.The Evolving Genotypic Profile of HIV-1 Mutations Related to Antiretroviral Treatment in the North Region of Brazil.Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistancePulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease.Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance.Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008)HIV-1 mutational pathways under multidrug therapy.CNS Impact of Perinatal HIV Infection and Early Treatment: the Need for Behavioral Rehabilitative Interventions Along with Medical Treatment and Care.HIV-1 protease codon 36 polymorphisms and differential development of resistance to nelfinavir, lopinavir, and atazanavir in different HIV-1 subtypes.In vitro selection of HIV-1 CRF08_BC variants resistant to reverse transcriptase inhibitors.Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine.Are all subtypes created equal? The effectiveness of antiretroviral therapy against non-subtype B HIV-1.A high HIV-1 strain variability in London, UK, revealed by full-genome analysis: Results from the ICONIC project.Molecular Epidemiology of HIV-1 virus in Puerto Rico: Novel Cases of HIV-1 Subtype C, D and CRF-24BG.
P2860
Q27660028-E2A662A8-217A-4ED8-9ED7-2870F40AD785Q28483726-15DA1712-7791-435B-B774-3FAF0D201264Q28550335-99517FB4-74A8-4C24-8C27-9424617D8F05Q28553083-211700C4-C54A-46D3-8574-739C1BFD4DB5Q30352010-5605CCC2-A91F-4F8D-8A6C-C9EE4DCF2A6EQ30394627-D9494FF4-26C8-4896-AB27-A71573171063Q33646675-D93D2B21-5BC0-482B-9566-53E242A429D1Q33681279-AC674D99-F6F1-4498-AE7B-614E579B753DQ33768822-C9492AB8-D390-4DA4-AAB1-98FE4333012EQ33851789-C84DF47A-C030-4764-8568-0DF5913D0A2AQ33927293-43871386-61C8-4BEE-AF83-855BFB0E5AA5Q34243467-D83ADF9F-7634-40C4-BE9C-AF842C3021D9Q34303603-CF2D7A45-DC4D-4A36-BE0E-609548E19589Q35260403-4998F14B-CF43-4DB1-A27F-16BA10C73261Q35261045-7FD070C8-0E32-47CA-BE3E-1897F5100765Q35607740-AF474ABE-92E9-4E21-AE58-39E6733F58F0Q35832732-EE1DCFCC-EB9F-4A78-86AA-19A5CE5F3CB4Q36077418-3EDF1472-47EC-4F19-84F5-01383E944369Q36099861-1D3E164C-9217-4DBE-92D1-C3CE9CDD563BQ36205277-3A034525-EC5D-4DF7-BFF3-E9ABA8E8C5F5Q36250342-11FCB160-3E26-46A6-9AD0-BFD7C664F6FCQ36418462-3C084F9F-DA9D-434C-A7AB-C329599D7D96Q36501787-F8DFB7FF-BE9D-4E71-82C9-F2D9D43B52C6Q36593975-7C8CC9B4-AB27-448A-9A6B-E9CD5C4026B9Q36664640-38E84E8D-3CB6-43FA-BF1D-9B90376DFB0AQ36799767-732743D2-F80F-4D10-A0FE-136BBCF751F7Q37268341-FF4FF31B-E57B-4D21-9841-3CC992A263A6Q38264403-DE0F9C0A-3253-4AB0-8725-2A11EACA7A21Q38991265-655F5EA6-456E-400D-83EC-5B4714C0EDB3Q39713096-7B557B3D-4917-405D-AF78-40F53A4F8C73Q41720036-16DB53F7-71A2-4345-B932-9C2D2E3B1AC5Q42360742-FD720746-C854-4794-B12B-225C7A3FB7FCQ42671473-0F791C80-D7F3-46EF-9D28-C84CEDF73FC4Q47547162-556A34B8-6EFD-4CB2-BD1D-D953021457C2Q52586895-60B6F27A-DD9D-472E-B652-D82F1938D466
P2860
Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of genetic diversity amon ...... ogic and biochemical evidence.
@en
Role of genetic diversity amon ...... ogic and biochemical evidence.
@nl
type
label
Role of genetic diversity amon ...... ogic and biochemical evidence.
@en
Role of genetic diversity amon ...... ogic and biochemical evidence.
@nl
prefLabel
Role of genetic diversity amon ...... ogic and biochemical evidence.
@en
Role of genetic diversity amon ...... ogic and biochemical evidence.
@nl
P2093
P1433
P1476
Role of genetic diversity amon ...... ogic and biochemical evidence.
@en
P2093
Jorge L Martínez-Cajas
Marina B Klein
Mark A Wainberg
Nitika Pant-Pai
P304
P577
2008-10-01T00:00:00Z